Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from HYTN Innovations Inc ( (TSE:HYTN) ) is now available.
HYTN Innovations Inc. has secured import permits from the UK and export permits from Health Canada to expand its international exports of Good Manufacturing Practice (GMP) cannabis products, amounting to over 400 kilograms. This move signifies HYTN’s strategic shift from a Canadian recreational cannabis producer to a global manufacturer of non-sterile pharmaceuticals, aligning with its commitment to meeting GMP standards and catering to the demands of regulated markets worldwide.
More about HYTN Innovations Inc
HYTN Innovations Inc. is a pharmaceutical company specializing in the formulation, manufacturing, marketing, and sale of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids and psilocybe-derived tryptamines. The company aims to become a leading provider of these products across federally regulated markets by identifying market opportunities and introducing innovative products through its advanced development platform.
YTD Price Performance: 48.15%
Average Trading Volume: 66,885
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$28.63M
Find detailed analytics on HYTN stock on TipRanks’ Stock Analysis page.
